The efficacy and safety of rituximab pre-treatment in allogeneic hematopoietic stem cell transplantation in pediatric patients with severe aplastic anemia [0.03%]
评估利妥昔单抗预处理allo-HSCT治疗儿童重型再生障碍性贫血的疗效及安全性研究
Wang Wei,Wu Jinjun,Chen Zhi et al.
Wang Wei et al.
Background: Severe aplastic anemia (SAA) is a life-threatening bone marrow failure disorder. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an important curative treatment for pediatric patients with SA...
Maintenance immunosuppressive regimens and cytomegalovirus infection: Association with delayed kidney graft function [0.03%]
维持免疫抑制方案与巨细胞病毒感染：移植物功能延迟的关联性分析
Carlos Eduardo Pereira Lima,Mac Dionys Rodrigues da Costa,Bruna Ribeiro Duque et al.
Carlos Eduardo Pereira Lima et al.
Introduction: Transplant success depends on adherence to maintenance immunosuppression and effective prevention of opportunistic infections; however, selecting the most appropriate regimen remains challenging. ...
T315I-mutated chronic myeloid leukemia with blast crisis relapse 10 years after allo-HSCT: A case report of second transplantation combined with olverembatinib maintenance therapy [0.03%]
T315I突变慢性髓性白血病加速期二次移植联合奥雷巴替尼维持治疗疗效观察：1例报告
YuTing Zhu,JiaJuan Ji,Dan Luo et al.
YuTing Zhu et al.
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of the Philadelphia chromosome and the resulting fusion proteins with abnormal tyrosine kinase activity. The treatment of CML includes allogeneic ...
Transfusion-induces donor-specific antibody boost leading to antibody-mediated rejection after heart transplantation: A case report [0.03%]
心脏移植后输血诱导的供者特异性抗体增强导致抗体介导排斥反应1例报告
B Panaget,E Epailly,G Hell et al.
B Panaget et al.
Despite significant advances in immunosuppression strategies, antibody-mediated rejection (AMR) remains a leading cause of graft dysfunction and loss after heart transplantation. Donor-specific anti-HLA antibodies (DSA), either preformed or...
The effect of eculizaumab combined with double filtration plasmapheresis in improving recovery outcomes in ABOi-KT patients [0.03%]
艾克利珠单抗联合双重滤过血浆置换在ABO血型不合肾移植患者中的应用效果分析
Zhaomei Wan,Xiaojin He,Junzhu Zhou et al.
Zhaomei Wan et al.
Background: ABO-incompatible kidney transplants are acceptable, but special considerations are critical. This study evaluated the efficacy of eculizumab, an antibody that blocks the cleavage of the complement C5 component...
Evaluation of desensitizing therapies for donor-specific antibodies in confirmed humoral allograft rejection in kidney transplantation: Experience of a center for 10 years [0.03%]
十年单中心确认的移植物排斥反应患者特异性抗体脱敏治疗效果评估
Marta Martínez-Alcaraz,Mercedes Gil,Santiago Llorente et al.
Marta Martínez-Alcaraz et al.
Donor-specific antibodies (DSAs) in the recipient's serum are directed against donor-mismatched Human Leukocyte Antigen (HLA) antigens found on graft endothelial cells. These DSAs may be responsible for antibody-mediated rejection (AMR) in ...
Assessing reference ranges for non-HLA antibodies: Comparative analysis of blood donors and kidney transplant candidates [0.03%]
评估非HLA抗体的参考范围：献血者和肾移植受者的比较分析
A Quintiliano,A Agrawal,M Zuccarelli et al.
A Quintiliano et al.
Background: The clinical relevance of non-HLA antibodies remains uncertain due to the lack of standardized assays. This study aimed to assess comparative reference values for non-HLA antibody profiles in a cohort of kidne...
Comparison of Total Leukocyte Chimerism and Lymphocyte Subset Chimerism for Early Detection of Post-Transplant Complications [0.03%]
总白细胞嵌合体与淋巴细胞亚群嵌合体在移植术后早期发现并发症中的对比研究
Metban Mastanzade,Figen Abatay Sel,İpek Yönal Hindilerden et al.
Metban Mastanzade et al.
Purpose: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is associated with risks of GVHD, graft rejection, and relapse. Chimerism monitoring supports early detection, though the prognostic value of B- and ...
Gamma delta T cell reconstitution in Acute Lymphoblastic Leukemia patients post allogeneic HSCT predicts clinical outcome and overall survival [0.03%]
异基因造血干细胞移植后急性淋巴细胞白血病患者γδT细胞重建预测临床结局及总生存率
Gauri Mirji,Sachin Punatar,Navin Khattry et al.
Gauri Mirji et al.
Predicting the transplant outcome of Acute Lymphoblastic Leukemia patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a challenge. It is necessary to have prognostic biomarkers that can be monitored in thes...
Bilateral lung transplantation for severe lung disease caused by a STING1 mutation: A case report [0.03%]
STING1基因突变所致严重肺病的双侧肺移植一例报告
Yan Lv,Qi Wang,Ke Wang et al.
Yan Lv et al.
Stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy (SAVI) is an autoinflammatory syndrome caused by mutations in the stimulator of interferon response cGAMP interactor 1 (STING1) gene, leading to lung and v...
Case Reports
Transplant immunology. 2026 Feb 4:102359. DOI:10.1016/j.trim.2026.102359 2026